145 related articles for article (PubMed ID: 7567694)
1. Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues.
Noordzij MA; van der Kwast TH; van Steenbrugge GJ; van Weerden WM; Oomen MH; Schröder FH
Prostate; 1995 Sep; 27(3):154-9. PubMed ID: 7567694
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue.
Birner P; Ritzi M; Musahl C; Knippers R; Gerdes J; Voigtländer T; Budka H; Hainfellner JA
Am J Pathol; 2001 Jun; 158(6):1991-6. PubMed ID: 11395376
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies--comparative studies on frozen and paraffin sections.
Remmele W; Mühlfait V; Keul HG
Virchows Arch; 1995; 426(5):435-9. PubMed ID: 7633653
[TBL] [Abstract][Full Text] [Related]
5. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.
Hoyt JW; Gown AM; Kim DK; Berger MS
J Neurooncol; 1995; 24(2):163-9. PubMed ID: 7562003
[TBL] [Abstract][Full Text] [Related]
8. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
10. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.
Hepburn PJ; Glynne-Jones E; Goddard L; Gee JM; Harper ME
Histochem J; 1995 Mar; 27(3):196-203. PubMed ID: 7797424
[TBL] [Abstract][Full Text] [Related]
12. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
13. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin sections.
Skálová A; Michal M
Am J Dermatopathol; 1995 Aug; 17(4):332-4. PubMed ID: 8600794
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue.
Dervan PA; Magee HM; Buckley C; Carney DN
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455
[TBL] [Abstract][Full Text] [Related]
15. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
16. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
17. Quality control considerations for Ki-67 detection and quantitation in paraffin-embedded tissue.
Hendricks JB; Wilkinson EJ
J Cell Biochem Suppl; 1994; 19():105-10. PubMed ID: 7823581
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
[TBL] [Abstract][Full Text] [Related]
19. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
Böni R; Doguoglu A; Burg G; Müller B; Dummer R
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
